Adolescent Attention to Emotion Study
Visuocortical Dynamics of Affect-Biased Attention in the Development of Adolescent Depression
2 other identifiers
interventional
15
1 country
1
Brief Summary
Rates of depression increase rapidly during adolescence, especially for girls, and, thus, research is needed to spur the development of novel interventions to prevent adolescent depression. This project seeks to determine if a novel visuocortical probe of affect-biased attention (i.e., steady-state visual evoked potentials derived from EEG) can 1) be used to prospectively predict depression using a multi-wave repeated measures design and 2) modify affect-biased attention and buffer subsequent mood reactivity using real time neurofeedback. This work could ultimately lead to improved identification of adolescents who are at high risk for depression and directly inform the development of mechanistic treatment targets to be used in personalized intervention prescriptions for high-risk youth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Oct 2019
Longer than P75 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2019
CompletedFirst Posted
Study publicly available on registry
September 26, 2019
CompletedStudy Start
First participant enrolled
October 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedResults Posted
Study results publicly available
November 13, 2025
CompletedNovember 13, 2025
October 1, 2025
4.9 years
September 24, 2019
September 24, 2025
October 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Affect-biased Attention Following Neurofeedback (Immediately Post-Intervention)
To measure affect-biased attention, steady-state visual evoked potentials (SSVEPs) were derived from EEG and used to index the amount of stimulus-driven attention to negative distractors relative to task-relevant stimuli. Affect-biased attention was assessed immediately before and immediately after the real-time SSVEP neurofeedback training to evaluate changes within the same session. The outcome below reflects the post-neurofeedback SSVEP competition index (Task / \[Task + Distractor\]). Scores above .50 indicate greater attention to the task stimulus.
Approximately 1 hour total: baseline assessment immediately before neurofeedback and post-neurofeedback assessment immediately after the ~1 hour training session on the same day.
Secondary Outcomes (2)
Sadness Ratings Following Laboratory Stressor (Immediately Post-Stressor)
Approximately 30 minutes total: baseline sadness rating immediately before and post-stressor rating immediately after the ~30-minute laboratory stressor on the same day.
Anxiety Rating Following Laboratory Stressor (Immediately Post-Stressor)
Baseline and following laboratory stressor (~30 minutes)
Study Arms (1)
Neurofeedback
EXPERIMENTALParticipants will receive feedback about their attention to negative distractors during each trial using activity from their brain waves, which will help them reduce their attention to distractors.
Interventions
Participants will receive feedback during a computerized task that is based on their own visuocortical activity evoked by attention to negative distractors and task-relevant stimuli on the computer screen.
Eligibility Criteria
You may qualify if:
- Participants will include 90 female adolescents ages 13 years 0 months through 15 years 11 months at study entry.
You may not qualify if:
- Lifetime history of any Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 depressive disorder
- Lifetime history of taking antidepressants \[e.g., selective serotonin reuptake inhibitor (SSRIs)\]
- Lifetime history of a DSM 5 psychotic, bipolar, or autistic spectrum disorder.
- Presence of EEG contraindications (e.g., personal lifetime history of seizures or family history of hereditary epilepsy).
- Being pre-pubertal
- Lifetime history of a neurological or serious medical condition.
- Lifetime history of head injury or congenital neurological anomalies (based on parent report).
- Intelligence quotient (IQ) less than 80, as assessed using the Wechsler Abbreviated Scale of Intelligence (WASI).
- Uncorrected visual disturbance
- Being acutely suicidal or at risk for harm to self or others.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Western Psychiatric Institute and Clinic
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (1)
Huang X, Mak J, Wears A, Price RB, Akcakaya M, Ostadabbas S, Woody ML. Using Neurofeedback from Steady-State Visual Evoked Potentials to Target Affect-Biased Attention in Augmented Reality. Annu Int Conf IEEE Eng Med Biol Soc. 2022 Jul;2022:2314-2318. doi: 10.1109/EMBC48229.2022.9871982.
PMID: 36085716DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The study was a small, single-arm pilot trial with 15 participants, which may limit generalizability. Results should be interpreted as preliminary pending replication in larger, controlled samples.
Results Point of Contact
- Title
- Mary Woody, PhD Assistant Professor of Psychiatry
- Organization
- University of Pittsburgh
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Woody, PhD
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 24, 2019
First Posted
September 26, 2019
Study Start
October 16, 2019
Primary Completion
September 23, 2024
Study Completion
March 30, 2025
Last Updated
November 13, 2025
Results First Posted
November 13, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
We will comply with all National Institute of Mental Health (NIMH) guidelines regarding data repository/sharing.